Subscribe to RSS
DOI: 10.1055/s-2006-947199
© Georg Thieme Verlag KG Stuttgart · New York
Antihyperglycemic Effect of Aporphines and their Derivatives in Normal and Diabetic Rats
Publication History
Received: October 28, 2005
Accepted: June 2, 2006
Publication Date:
21 August 2006 (online)
Abstract
The antihyperglycemic actions of some aporphines and their derivatives in normal Wistar, streptozotocin (STZ)-induced diabetic (IDDM) and nicotinamide-STZ induced diabetic (NIDDM) rats were investigated in this study. These compounds included thaliporphine, glaucine, boldine, N-methyllaurotetanine, and predicentrine and the derivatives, N-[2-(2-methoxyphenoxy)ethyl]norglaucine and diacetyl-N-allylsecoboldine. Bolus intravenous injection of these compounds decreased the plasma glucose levels in a dose-dependent manner in both normal and diabetic rats. Among them, thaliporphine was found to have the most potent antihyperglycemic effect in both NIDDM and IDDM diabetic rats. It was found that thaliporphine could stimulate the release of insulin in both normal and diabetic rats, and a dose of 1 mg per kg thaliporphine could significantly attenuate the increase of plasma glucose induced by an intravenous glucose challenge test in normal rats. Similar treatment with thaliporphine significantly increased the skeletal muscle glycogen synthesis in both normal and diabetic rats. Hence, the hypoglycemic effect of thaliporphine in diabetic rats could be attributed to the stimulation of insulin release and the increase of glucose utilization.
Key words
Aporphine - Thaliporphine - Diabetic rats - NIDDM - IDDM - anti-hyperglycemia
References
- 1 Lopez-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med. 2001; 32 283-300
- 2 Rao N SK, Lee S S. Preparation of thaliporphine and liioferine from glaucine by treatment with hydrogen bromide. J Clin Chem Soc. 2000; 47 227-30
- 3 Lee S S, Lin Y J, Chen M Z, Wu Y C, Chen C H. A facile semisynthesis of litebamine, a novel phenanthrene alkaloid, from boldine via a biogenetical approach. Tetrahedron Lett. 1992; 33 6309-10
- 4 Guinaudeau H, Leboenf L M, Cave A. Aporphine alkaloids. J Nat Prod. 1975; 38 275
- 5 Huang W J, Chen C H, Singh O V, Lee S L, Lee S S. A facile method for the synthesis of glaucine and norglaucine from boldine. Synth Commun. 2002; 32 3681-6
- 6 Hung L M, Lee S S, Chen J K, Huang S S, Su M J. Thaliporphine protects ischemic and ischemic-reperfused rat hearts via an NO-dependent mechanism. Drug Dev Res. 2001; 52 446-53
- 7 Su M J, Chang Y M, Chi J F, Lee S S. Thaliporphine, a positive inotropic agent with a negative chronotropic action. Eur J Pharmacol. 1994; 254 141-50
- 8 Forman L J, Estilow S, Mead J, Vasilenko P. Eight weeks of streptozotocin-induced diabetes induces the effects of cold stress on immunoreactive beta-endorphin levels in female rats. Horm Metab Res. 1988; 20 555-8
- 9 Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buye D. et al . Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998; 47 224-9
- 10 Jansson L, Carlsson P O, Bodin B, Andersson A, Kallskog O. Neuronal nitric oxide synthase and splanchnic blood flow in anaesthetized rats. Acta Physiol Scand. 2005; 183 257-62
- 11 Pratz J, Mondot S, Montier F, Cavero I. Effect of K+ channel activators, RP52891, cromakalim and diazoxide, on the plasma insulin level, plasma rennin activity and blood pressure in rats. J Pharmacol Exp Ther. 1991; 21 216-22
- 12 Garrel D R, Picq R, Bajard L, Harfouche M, Tourniaire J. Acute effect of glyburide on insulin sensitivity in type I diabetic patients. J Clin Endocrinol Metab. 1987; 65 896-900
- 13 Chou C H, Tsai Y L, Hou C W, Lee H H, Chang W H, Lin T W. et al . Glycogen overload by postexercise insulin administration abolished the exercise-induced increase in GLUT4 protein. J Biomed Sci. 2005; 12 991-8
- 14 Yu B C, Hung C R, Chen W C, Cheng J T. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003; 69 1075-9
M. J. Su, Ph. D.
Institute of Pharmacology
College of Medicine
National Taiwan University
No. K1, Sec. 1, Jen-Ai Rd
Taipei
Taiwan
Republic of China
Phone: +886-2-2312-3456 ext. 8317
Fax: +886-2-2397-1403
Email: mjsu@ha.mc.ntu.edu.tw